The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A single-center retrospective study of patients treated with trabectedin (TRB) with long-term follow up.
 
Brett A. Schroeder
No Relationships to Disclose
 
Chad He
No Relationships to Disclose
 
Yuzheng Zhang
No Relationships to Disclose
 
Michael Wagner
Consulting or Advisory Role - Tempus
Research Funding - Merck (Inst)
 
Robin Lewis Jones
Consulting or Advisory Role - Adaptimmune; Blueprint Medicines; Clinigen Group; Daiichi Sankyo; Deciphera; Eisai; Epizyme; Immodulon Therapeutics; Immune Design; Lilly; Merck Serono; Morphotek; PharmaMar; TRACON Pharma
Research Funding - GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Lee D. Cranmer
Consulting or Advisory Role - Blueprint Medicines
Research Funding - AADi (Inst); Advenchen Laboratories (Inst); Lilly (Inst)
 
Seth Pollack
Consulting or Advisory Role - Amgen; Bayer; Lilly; Nektar; Omeros; PureTech; Tempus
Research Funding - EMD Serono (Inst); Epizyme (Inst); Immune Design (Inst); Janssen Oncology; Karyopharm Therapeutics (Inst); Lilly/ImClone (Inst); Merck (Inst); OncoSec; Presage Biosciences (Inst)
Travel, Accommodations, Expenses - Lilly/ImClone